OptimizeRx Corp — Director's Dealing 2024

Jun 11, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2024-06-05

Reporting Person: WASSON GREGORY D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-05	Common Stock	M	10061	—	Acquired	34029	Direct
2024-06-07	Common Stock	A	13286	—	Acquired	47315	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-05	Restricted Stock Units	$	M	10061	Disposed		Common Stock (10061)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

F3: On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024.